Akero Therapeutics, Inc.
AKRO
$54.20
-$0.70-1.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 686.29M | 743.08M | 717.25M | 760.19M | 903.67M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.86M | 27.30M | 29.64M | 15.82M | 7.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 713.15M | 770.38M | 746.89M | 776.01M | 911.28M |
|
|
|||||
| Total Current Assets | 713.15M | 770.38M | 746.89M | 776.01M | 911.28M |
| Net Property, Plant & Equipment | 689.00K | 755.00K | 835.00K | 900.00K | 963.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.16B | 825.89M | 817.55M | 865.04M | 912.24M |
|
|
|||||
| Total Accounts Payable | 10.83M | 9.03M | 25.22M | 14.57M | 13.78M |
| Total Accrued Expenses | 24.30M | 30.10M | 17.44M | 15.98M | 15.84M |
| Short-term Debt | 6.66M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 299.00K | 291.00K | 283.00K | 275.00K | 267.00K |
| Total Finance Division Other Current Liabilities | 346.00K | 340.00K | 348.00K | 354.00K | 373.00K |
| Total Other Current Liabilities | 346.00K | 340.00K | 348.00K | 354.00K | 373.00K |
| Total Current Liabilities | 42.44M | 39.75M | 43.29M | 31.17M | 30.26M |
|
|
|||||
| Total Current Liabilities | 42.44M | 39.75M | 43.29M | 31.17M | 30.26M |
| Long-Term Debt | 28.81M | 35.30M | 35.12M | 34.96M | 34.80M |
| Short-term Debt | 6.66M | -- | -- | -- | -- |
| Capital Leases | 451.00K | 529.00K | 605.00K | 679.00K | 750.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 296.00K | 194.00K | 203.00K | 164.00K | 178.00K |
| Total Liabilities | 72.00M | 75.77M | 79.22M | 66.98M | 65.99M |
|
|
|||||
| Common Stock & APIC | 1.98B | 1.58B | 1.49B | 1.48B | 1.47B |
| Retained Earnings | -896.88M | -826.16M | -756.13M | -683.43M | -627.44M |
| Treasury Stock & Other | 1.09M | 948.00K | 2.10M | -261.00K | -79.00K |
| Total Common Equity | 1.08B | 750.11M | 738.33M | 798.07M | 846.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.08B | 750.11M | 738.33M | 798.07M | 846.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.08B | 750.11M | 738.33M | 798.07M | 846.25M |
|
|
|||||